Fig. 3From: miR-26a inhibits atherosclerosis progression by targeting TRPC3Effects of miR-26a on the production of inflammatory factors in HFD-treated apoE−/− mice. ELISA assay of concentrations of TNF-α (a), IL-1β (b), IL-6 (c), and MCP-1 (d) in the plasma of HFD-treated apoE−/− mice from control, AG, AG-NC, AN, and AN-NC groups. *P < 0.05Back to article page